The regulatory landscape for peptide compounds has undergone significant transformations over the past three years. Following the controversial restriction of numerous widely-used peptides in late 2023, the year 2026 has marked a pivotal turning point in peptide classification and availability. For research laboratories, clinicians, and the scientific community, understanding these regulatory shifts is crucial for […]
